Trends in the epidemiology of chronic obstructive pulmonary disease in England: A national study of 51 804 patients

British Journal of General Practice

Volumn 60, Issue 576, 2010, Pages

  Simpson, Colin R ^a   Hippisley Cox, Julia ^b   Sheikh, Aziz ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; General practice; QRESEARCH; Socioeconomic status

Indexed keywords

ADULT; ARTICLE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CROSS-SECTIONAL STUDY; CULTURAL DEPRIVATION; FEMALE; GENERAL PRACTICE; GEOGRAPHY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PREVALENCE; SEX DIFFERENCE; SOCIOECONOMICS; UNITED KINGDOM;

CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HUMANS; INCIDENCE; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDENCE CHARACTERISTICS; SMOKING; SOCIOECONOMIC FACTORS;

EID: 78650493167     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X514729     Document Type: Article

References (26)

1. World Health Organization. World Health Report: life in the 21st century: a vision for all. Geneva: World Health Organization, 1998.
2. Niu S, Yang G, Chen Z, et al. Emerging tobacco hazards in china: 2. early mortality results from a prospective study. BMJ 1998; 317 (7170): 1423-1424. (Pubitemid 28522093)
3. Calverley PMA. Caring for the burden of COPD. Thorax 2006; 61 (10): 831-832.
4. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55 (9): 789-794.
5. Her Majesty's Treasury. 2004 spending review public service agreements 2005-8. London: Her Majesty's Treasury, 2004.
6. Simpson CR, Hippisley-Cox J, Sheikh A. Trends in the epidemiology of smoking in the United Kingdom, Br J Gen Pract 2010; 10.3399/bjgp10X483544.
7. The Chief Medical Officer. On the state of the public health: annual report of the Chief Medical Officer. London: The Department of Health, 2005.
8. Hippisley-Cox J, Vinogradova Y, Coupland C, Pringle M. Comparison of key practice characteristics between general practices in England and Wales and general practices in the QRESEARCH data. http://www.qresearch.org/Public- Documents/Characteristics%20of %20QRESEARCH%20practices%20- database%20version%208-% 20v10.pdf (accessed 1 Jun 2010).
9. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101 (3): 139-143.
10. Ghouri N, Hippisley-Cox J, Newton J, Sheikh A. Trends in the epidemiology and prescribing of medication for allergic rhinitis in England. J R Soc Med 2008; 101 (9): 466-472.
11. Simpson CR, Newton J, Hippisley-Cox J, Sheikh A. Incidence and prevalence of multiple allergic disorders recorded in a national primary care database. J R Soc Med. 2008; 101 (11): 558-563.
12. Simpson CR, Newton J, Hippisley-Cox J, Sheikh A. Trends in the epidemiology and prescribing of medication for eczema in England. J R Soc Med 2009; 102 (3): 108-117.
13. Office for National Statistics. The 2001 census. http://www.ons.gov.uk/ census/index.html (accessed 18 Jan 2010).
14. The NHS Confederation. Investing in general practice: the new General Medical Services contract. London: British Medical Association. http://www.bma.org.uk/employmentandcontracts/independent-co ntractors/general- medical-services-contract/investinggp.jsp (accessed 18 Jan 2010).
15. Wolfenden H, Bailey L, Murphy K, Partridge MR. Use of an open access spirometry service by general practitioners. Prim Care Respir J 2006; 15 (4): 252-255. (Pubitemid 44129079)
16. Soriano JB, Vestbo J, Pride NB, et al. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20 (4): 819-825.
17. De Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007; 175 (1): 32-39.
18. Johannessen A, Omenaas E, Bakke P, Gribbin J. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005; 9 (80): 926-932.
19. Frank TL, Hazell ML, Linehan MF, et al. The estimated prevalence of chronic obstructive pulmonary disease in a general practice population. Prim Care Respir J 2007; 16 (3): 169-173.
20. Bischoff EWMA, Schermer TRJ, Bor H, et al. Trends in the COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract 2009; 59: 927-933.
21. Nacul LC, Soljak M, Meade T. Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England. Popul Health Metr 2007; 5: 8. (Pubitemid 350226883)
22. The Prescribing Support Unit. Quality and Outcome Framework disease prevalence for April 2007 to March 2008, England. Leeds: The Health and Social Care Information Centre, 2008.
23. Smith CJP, Gribben J, Challen KB, Hubbard RB. The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. Q J Med 2008; 101 (2): 145-153.
24. Britton M. The burden of COPD in the UK. Results from the confronting COPD survey. Resp Med. 2003; 97: S71-S79.
25. Jones R. Can early diagnosis and effective management combat the irresistible rise of COPD. Br J Gen Pract 2006; 56 (530): 652-654.
26. The British Lung Foundation. National clinical strategy for COPD. London: The British Lung Foundation. http://www.lunguk.org/media-and-campaigning/ campaigns/what-is-the-national-strategy-for-copd. htm (accessed 18 Jan 2010).